289P Risk factors for interstitial lung disease in patients treated with trastuzumab deruxtecan from two interventional studies
| Autor: | Powell, C.A., Camidge, D.R., Modi, S., Qin, A., Taitt, C., Lee, C., Hackshaw, M.D., Singh, J., Iwata, H. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S357-S358 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|